Megapro Biomedical News Today : Breaking News, Live Updates

Anemia Market to witness growth by 2032, estimates DelveInsight | Akebia Therapeutics, GlaxoSmithKline, Nemysis, MegaPro Biomedical

Published: October 9, 2023

"Anemia Market"(Albany, USA) DelveInsight's "Anemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Anemia, historical and forecasted epidemiology as well as the

Source: benzinga.com

MegaPro Biomedical MPB-1734 Receives Composition Patent for New Dosage Form of Anticancer Drug which enhanced the immune-combination therapy

Published: November 15, 2022

DJ MegaPro Biomedical MPB-1734 Receives Composition Patent for New Dosage Form of Anticancer Drug which enhanced the immune-combination therapy EQS Newswire / 15/11/2022 / 10:41 UTC+8 MegaPro Biomedical

Source: finanznachrichten.de

Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study

Published: March 31, 2022

Significance Statement Iron supplementation and erythropoiesis-stimulating agents (ESAs) are curr

Source: asnjournals.org

Cold Agglutinin Disease Market to Exhibit Massive Growth at a CAGR of 28% in the 7MM for the Study Period of 2019-32

Published: March 30, 2022

/PRNewswire/ -- DelveInsight's Cold Agglutinin Disease Market Insights report proffers a detailed comprehension of Cold Agglutinin Disease market size by...

Source: prnewswire.com

DelveInsight Business Research, LLP: Warm Autoimmune Hemolytic Anemia Market is Expected to Witness Growth at an Accelerated CAGR of 14.7% in the 7MM for the Study Period 2018-30, Assesses DelveInsight

Published: February 28, 2022

LAS VEGAS, Feb. 28, 2022 /PRNewswire/ -- The launch of key Warm Autoimmune Hemolytic Anemia (WAIHA) assets such as Fostamitinib (Rigel Pharmaceuticals) and APL2 (Apellis Pharmaceuticals), which